Salivary microRNA profiling dysregulation in autism spectrum disorder: A pilot study

Abstract

IntroductionAutism spectrum disorders (ASD) are the most prevalent neurobiological disorders in children. The etiology comprises genetic, epigenetic, and environmental factors such as dysfunction of the immune system. Epigenetic mechanisms are mainly represented by DNA methylation, histone modifications, and microRNAs (miRNA). The major explored epigenetic mechanism is mediated by miRNAs which target genes known to be involved in ASD pathogenesis. Salivary poly-omic RNA measurements have been associated with ASD and are helpful to differentiate ASD endophenotypes. This study aims to comprehensively examine miRNA expression in children with ASD and to reveal potential biomarkers and possible disease mechanisms so that they can be used to improve faction between individuals by promoting more personalized therapeutic approaches.Materials and methodsSaliva samples were collected from 10 subjects: 5 samples of children with ASD and 5 from healthy controls. miRNAs were analyzed using an Illumina Next-Generation-Sequencing (NGS) system.ResultsPreliminary data highlighted the presence of 365 differentially expressed miRNAs. Pathway analysis, molecular function, biological processes, and target genes of 41 dysregulated miRNAs were assessed, of which 20 were upregulated, and 21 were downregulated in children with ASD compared to healthy controls.ConclusionThe results of this study represent preliminary but promising data, as the identified miRNA pathways could represent useful biomarkers for the early non-invasive diagnosis of ASD.

Once upon a Time Oral Microbiota: A Cinderella or a Protagonist in Autism Spectrum Disorder?

“…In patients with ASD, comorbidities are very frequent, especially gastrointestinal (GI) disease, the most common medical condition associated with ASD [4], periodontal diseases, and allergies [5,6]. Autism is also associated with several oropharyngeal impairments, including buccal sensory sensitivity, taste and texture reluctances, and salivary transcriptome alterations [7,8].…”